CVR Partners, LP (UAN)
NYSE · Agricultural Chemicals · Manufacturing · CIK 1425292 · fiscal year ends in Dec
Closing price $125.79 on 29 Oct 2026; 52-week range $91.76 to $139.00.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $676.9M
- Revenue growth
- 17.5%
- Net income, last twelve months
- $160.2M
- Earnings per share
- $15.16
- Gross margin
- 33.5%
- Operating margin
- 28.1%
- Net margin
- 23.7%
- Free cash flow
- $144.6M
- Market value
- $1.3B
- Price to earnings
- 8.3x
- Cash
- $137.5M
- Debt
- $569.0M
- Shares outstanding
- 10.6M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $606.0M | $128.7M | $98.7M | $9.33 | $98.8M | 10-K filed 18 Feb 2026 |
| FY2024 | 31 Dec 2024 | $525.3M | $90.4M | $60.9M | $5.76 | $113.5M | 10-K filed 19 Feb 2025 |
| FY2023 | 31 Dec 2023 | $681.5M | $201.4M | $172.4M | $16.31 | $219.3M | 10-K filed 21 Feb 2024 |
| FY2022 | 31 Dec 2022 | $835.6M | $319.9M | $286.8M | $27.07 | $256.8M | 10-K filed 22 Feb 2023 |
| FY2021 | 31 Dec 2021 | $532.6M | $134.5M | $78.2M | $7.31 | $168.1M | 10-K filed 23 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $202.2M | $77.5M | $7.33 |
| Q1 FY2026 | 31 Mar 2026 | $180.0M | $49.9M | $4.72 |
| Q4 FY2025 | 31 Dec 2025 | $131.1M | -$10.3M | -$0.97 |
| Q3 FY2025 | 30 Sep 2025 | $163.5M | $43.1M | $4.08 |
| Q2 FY2025 | 30 Jun 2025 | $168.6M | $38.8M | $3.67 |
| Q1 FY2025 | 31 Mar 2025 | $142.9M | $27.1M | $2.56 |
| Q4 FY2024 | 31 Dec 2024 | $139.6M | $18.3M | $1.73 |
| Q3 FY2024 | 30 Sep 2024 | $125.2M | $3.8M | $0.36 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| UAN | $374.3M | 61.8% |
| Ammonia | $143.1M | 23.6% |
| Other revenue | $51.2M | 8.5% |
| Urea products | $37.4M | 6.2% |
Company events
The newest 8-K filings of 188 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 29 Jul 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 23 Jun 2026 | 8-K | Leadership change, Other events | 5.02, 8.01, 9.01 |
| 29 Apr 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 18 Mar 2026 | 8-K | Leadership change, Bylaws or fiscal year change | 5.02, 5.03 |
| 3 Mar 2026 | 8-K | Delisting notice | 3.01 |
| 18 Feb 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 26 Jan 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 22 Jan 2026 | 8-K | Leadership change | 5.02 |
| 5 Jan 2026 | 8-K | Investor update | 7.01, 9.01 |
| 29 Oct 2025 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 30 Jul 2025 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 6 Jun 2025 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07, 9.01 |
Every filing
The newest filings with the SEC of 317 held.
| Filed | Form | Period |
|---|---|---|
| 29 Jul 2026 | 10-Q | 30 Jun 2026 |
| 29 Jul 2026 | 8-K | 29 Jul 2026 |
| 23 Jun 2026 | 8-K | 18 Jun 2026 |
| 29 Apr 2026 | 10-Q | 31 Mar 2026 |
| 29 Apr 2026 | 8-K | 29 Apr 2026 |
| 18 Mar 2026 | 8-K | 17 Mar 2026 |
| 3 Mar 2026 | 8-K | 25 Feb 2026 |
| 18 Feb 2026 | 10-K | 31 Dec 2025 |
| 18 Feb 2026 | 8-K | 18 Feb 2026 |
| 26 Jan 2026 | 8-K | 26 Jan 2026 |
| 22 Jan 2026 | 8-K | 16 Jan 2026 |
| 5 Jan 2026 | 8-K | 5 Jan 2026 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 199.3K | -10.57% | 9.41 |
| 30 Sep 2026 | 222.9K | -11.04% | 8.93 |
| 15 Sep 2026 | 250.5K | -13.53% | 8.63 |
| 31 Aug 2026 | 289.7K | -7.62% | 6.23 |
| 14 Aug 2026 | 313.6K | +11.26% | 4.57 |
| 31 Jul 2026 | 281.8K | +0.12% | 10.04 |
| 15 Jul 2026 | 281.5K | -7.99% | 8.18 |
| 30 Jun 2026 | 306.0K | +3.23% | 7.46 |
Funds that hold it
From each fund's latest Form 13F.
86 funds held it at 30 Jun 2026: 36 added and 14 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| Icahn Carl C | 4,164,274 | $464.2M | 0 |
| Morgan Stanley | 438,977 | $48.9M | -94,378 |
| JPMorgan Chase & Co. | 187,535 | $21.1M | +63,465 |
| Mirae Asset Global ETFS Holdings Ltd. | 142,552 | $15.9M | +5,530 |
| UBS Group AG | 138,304 | $15.4M | -33,713 |
| Ing Groep NV | 83,100 | $9.3M | +24,000 |
| Oxbow Advisors, LLC | 70,310 | $7.8M | +542 |
| De Lisle Partners LLP | 54,233 | $6.1M | +600 |
| Natixis | 45,000 | $5.0M | 0 |
| Goldman Sachs Group Inc. | 43,626 | $4.9M | +3,221 |
Peers
Companies in the same industry.
- Nutrien Ltd. (NTR): revenue $26.9B, market value $33.0B
- CF Industries Holdings, Inc. (CF): revenue $7.7B, market value $17.9B
- Mosaic Co. (MOS): revenue $12.2B, market value $5.8B
- Scotts Miracle-Gro Co. (SMG): revenue $3.4B, market value $3.6B